Ad is loading...
BMRN
Price
$63.42
Change
-$2.18 (-3.32%)
Updated
Nov 15 closing price
94 days until earnings call
ITOS
Price
$8.23
Change
-$0.23 (-2.72%)
Updated
Nov 15 closing price
121 days until earnings call
Ad is loading...

BMRN vs ITOS

Header iconBMRN vs ITOS Comparison
Open Charts BMRN vs ITOSBanner chart's image
BioMarin Pharmaceutical
Price$63.42
Change-$2.18 (-3.32%)
Volume$1.69M
CapitalizationN/A
iTeos Therapeutics
Price$8.23
Change-$0.23 (-2.72%)
Volume$1.05M
CapitalizationN/A
BMRN vs ITOS Comparison Chart
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BMRN vs. ITOS commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Sell and ITOS is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BMRN: $63.42 vs. ITOS: $8.23)
Brand notoriety: BMRN and ITOS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 95% vs. ITOS: 135%
Market capitalization -- BMRN: $12.09B vs. ITOS: $300.57M
BMRN [@Biotechnology] is valued at $12.09B. ITOS’s [@Biotechnology] market capitalization is $300.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileITOS’s FA Score has 1 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • ITOS’s FA Score: 1 green, 4 red.
According to our system of comparison, ITOS is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 4 TA indicator(s) are bullish while ITOS’s TA Score has 3 bullish TA indicator(s).

  • BMRN’s TA Score: 4 bullish, 4 bearish.
  • ITOS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than ITOS.

Price Growth

BMRN (@Biotechnology) experienced а -5.44% price change this week, while ITOS (@Biotechnology) price change was -11.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

BMRN is expected to report earnings on Feb 20, 2025.

ITOS is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($12.1B) has a higher market cap than ITOS($301M). ITOS YTD gains are higher at: -24.840 vs. BMRN (-34.225). BMRN has higher annual earnings (EBITDA): 507M vs. ITOS (-136.64M). BMRN has more cash in the bank: 930M vs. ITOS (571M). ITOS has less debt than BMRN: ITOS (5.52M) vs BMRN (603M). BMRN has higher revenues than ITOS: BMRN (2.75B) vs ITOS (35M).
BMRNITOSBMRN / ITOS
Capitalization12.1B301M4,020%
EBITDA507M-136.64M-371%
Gain YTD-34.225-24.840138%
P/E Ratio38.20N/A-
Revenue2.75B35M7,866%
Total Cash930M571M163%
Total Debt603M5.52M10,932%
FUNDAMENTALS RATINGS
BMRN: Fundamental Ratings
BMRN
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
77
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMRNITOS
RSI
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
70%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
64%
Bullish Trend 7 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
58%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
64%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Ad is loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
EOS.X0.6727470.090494
+15.54%
EOS cryptocurrency
BULL.X0.0847100.005664
+7.17%
Tron Bull cryptocurrency
ONE.X0.0149540.000999
+7.16%
Harmony cryptocurrency
VIDT.X0.0337320.001629
+5.07%
VIDT DAO cryptocurrency
PVI24.81-0.08
-0.31%
Invesco Floating Rate MunicipalIncomeETF

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with IBO. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then IBO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-3.32%
IBO - BMRN
59%
Loosely correlated
+19.12%
SRPT - BMRN
45%
Loosely correlated
-4.19%
AXON - BMRN
42%
Loosely correlated
-0.86%
ITOS - BMRN
41%
Loosely correlated
-2.72%
FGEN - BMRN
41%
Loosely correlated
-9.52%
More

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with IBO. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then IBO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
-2.72%
IBO - ITOS
44%
Loosely correlated
+19.12%
BMRN - ITOS
41%
Loosely correlated
-3.32%
RCUS - ITOS
41%
Loosely correlated
-0.44%
NVAX - ITOS
39%
Loosely correlated
+1.39%
STRO - ITOS
38%
Loosely correlated
-16.23%
More